Essential thrombocythemia presenting as acute coronary syndrome: case reports and literature review
Authors:
- 11 March 2017
- journal article
- case report
- Published by Springer Nature in Journal of Thrombosis and Thrombolysis
- Vol. 44 (1) , 57-62
Abstract
For the patients with essential thrombocythemia (ET), systemic thrombosis presents as one of the most dangerous complications. It’s been widely accepted that acute coronary syndrome (ACS) is a kind of thrombotic diseases. However, there are very few case reports about ET first presenting as ACS. For some patients diagnosed as ACS, but without markedly elevated platelet, underlying ET was missed. And there are some controversies in the principles and target of treatment in those patients. We reported three cases of ACS, in which the patients who did not have common risk factors for coronary artery diseases and presented only mild atherosclerotic stenosis during coronary angiography, one of which had recurrent coronary artery thrombosis. Noticing their elevated blood platelet level and characteristics in angiography, diagnosis of ET was made according to bone marrow morphology and genetic tests. Although they had only mild thrombocytosis, we applied intensive treatment with dual anti-platelet therapy combined with cytoreduction in addition to early coronary intervention, having satisfying outcomes. During the diagnosis and treatment of ACS, if patients present thrombocytosis, but lack common coronary disease risk factors and thrombotic coronary artery occlusion, cardiologists should search for possible ET as an underlying cause of thrombotic coronary event. All those patients were high-risk according to ET risk stratification. Treatment of cytoreduction in combination with anti-thrombosis therapy and revascularization are beneficial. Treatment aims at the target of complete response with platelet count below 400 × 109/L.Keywords
This publication has 19 references indexed in Scilit:
- Thrombosis in essential thrombocytemia and early/prefibrotic primary myelofibrosis: the role of the WHO histological diagnosisDiagnostic Pathology, 2015
- Acute ST-segment elevation myocardial infarction in a young patient with essential thrombocythemia: a case with long-term follow-up reportJournal of Blood Medicine, 2014
- Infarctus du myocarde révélateur d’une thrombocytémie essentielle chez un sujet jeune noir africain: à propos d’une observationPan African Medical Journal, 2014
- How I treat essential thrombocythemiaBlood, 2011
- Guideline for investigation and management of adults and children presenting with a thrombocytosisBritish Journal of Haematology, 2010
- Acute coronary syndrome associated with essential thrombocythemiaJournal of Cardiology, 2009
- Trombocitosis esencial e infarto de miocardioRevista Espanola de Cardiologia, 2009
- Recurrent thrombosis in patients with polycythemia vera and essential thrombocythemia: incidence, risk factors, and effect of treatmentsHaematologica, 2008
- Hydroxyurea Compared with Anagrelide in High-Risk Essential ThrombocythemiaNew England Journal of Medicine, 2005
- Aggressive Antiplatelet Therapy Before Coronary Stent Implantation in Acute Coronary Syndrome with Essential ThrombocythemiaAngiology, 2003